- Home
- SGMO vs NRO Comparison
SGMO vs NRO Comparison
Compare SGMO & NRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- NRO
- Stock Information
- Founded
- SGMO 1995
- NRO 2003
- Country
- SGMO United States
- NRO United States
- Employees
- SGMO N/A
- NRO N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- NRO Finance/Investors Services
- Sector
- SGMO Health Care
- NRO Finance
- Exchange
- SGMO Nasdaq
- NRO Nasdaq
- Market Cap
- SGMO 180.5M
- NRO 187.8M
- IPO Year
- SGMO 2000
- NRO N/A
- Fundamental
- Price
- SGMO $2.51
- NRO $3.41
- Analyst Decision
- SGMO Buy
- NRO
- Analyst Count
- SGMO 3
- NRO 0
- Target Price
- SGMO $7.00
- NRO N/A
- AVG Volume (30 Days)
- SGMO 7.3M
- NRO 239.4K
- Earning Date
- SGMO 11-12-2024
- NRO 01-01-0001
- Dividend Yield
- SGMO N/A
- NRO 11.41%
- EPS Growth
- SGMO N/A
- NRO N/A
- EPS
- SGMO N/A
- NRO N/A
- Revenue
- SGMO $52,291,000.00
- NRO N/A
- Revenue This Year
- SGMO N/A
- NRO N/A
- Revenue Next Year
- SGMO $11.46
- NRO N/A
- P/E Ratio
- SGMO N/A
- NRO N/A
- Revenue Growth
- SGMO N/A
- NRO N/A
- 52 Week Low
- SGMO $0.30
- NRO $2.51
- 52 Week High
- SGMO $3.18
- NRO $3.45
- Technical
- Relative Strength Index (RSI)
- SGMO 55.54
- NRO 20.42
- Support Level
- SGMO $2.24
- NRO $3.34
- Resistance Level
- SGMO $2.82
- NRO $3.59
- Average True Range (ATR)
- SGMO 0.28
- NRO 0.07
- MACD
- SGMO 0.02
- NRO -0.04
- Stochastic Oscillator
- SGMO 52.88
- NRO 3.85
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. The fund invests in sectors, such as apartments, Data Centers, Infrastructure REITs, Manufactured Homes, Office, Regional Malls and others.